Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Local anti-inflammatory effect" refers to the physiological process where inflammation is reduced at a specific injury site, such as skeletal muscle or skin wounds, primarily through early clearance of neutrophils and decreased expression of pro-inflammatory mediators like S100A9, IL-1β, IL-6, and TNF-α.[1][2] This effect is observed in response to interventions like manual therapy, which inhibits neutrophil activation (marked by Ly6g+ and Mpo+ cells) and S100A9 protein in injured tibialis anterior muscle, thereby mitigating cytokine-driven damage without altering muscle cross-sectional area.[1] In wound healing, it involves modulating immune responses to limit neutrophil infiltration, reactive oxygen species, and macrophage polarization toward pro-reparative M2 states, promoting progression to proliferation and remodeling phases.[2] Neutrophils dominate early inflammation (first 24-72 hours), recruited by cytokines like IL-6 and TGF-β, and excessive persistence prolongs healing or causes scarring.[2][3] Therapies achieving this effect, such as chitosan-based dressings or photobiomodulation, reduce TNF-α and oxidative stress locally while enhancing angiogenesis and collagen deposition.[2][4] It plays a key role in acute injury repair but, if dysregulated, contributes to chronic conditions like non-healing wounds in diabetes.[2][5] No single molecular target defines it; instead, it emerges from coordinated suppression of innate immune effectors at the site.[1][3] Drug interactions are indirect, targeting upstream pathways like NF-κB or cytokine production rather than a dedicated receptor.[4] Overall, understanding this effect guides therapies for localized tissue repair, emphasizing timely neutrophil resolution over broad immunosuppression.[1][2]
Localized suppression of inflammation, involving immune cell modulation and cytokine reduction; achieved through early clearance of neutrophils, decreased expression of pro-inflammatory mediators (e.g., S100A9, IL-1β, IL-6, TNF-α), inhibition of neutrophil activation (e.g., Ly6g+, Mpo+ cells), limiting neutrophil infiltration, reducing reactive oxygen species, and promoting macrophage polarization toward pro-reparative M2 states.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Local anti-inflammatory effect.